Triquint Semiconductor (TQNT) 10-Q 6 Nov 13 2013 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information Document	9 Months Ended
	Sep. 28, 2013	Oct. 28, 2013
Document Information [Line Items]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Entity Common Stock, Shares Outstanding	'	160,605,803
Document Period End Date	28-Sep-13	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q3	'
Trading Symbol	'TQNT	'
Entity Registrant Name	'TRIQUINT SEMICONDUCTOR INC	'
Entity Central Index Key	'0000913885	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Well-known Seasoned Issuer	'No	'

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 28, 2013	Sep. 29, 2012	Sep. 28, 2013	Sep. 29, 2012
Revenue	$250,836	$200,821	$625,148	$595,553
Cost of goods sold	158,619	139,208	437,440	426,413
Gross profit	92,217	61,613	187,708	169,140
Operating expenses:	'	'	'	'
Research, development and engineering	47,023	40,871	140,201	116,029
Selling, general and administrative	26,420	26,264	79,650	86,620
Total operating expenses	73,443	67,135	219,851	202,649
Income (loss) from operations	18,774	-5,522	-32,143	-33,509
Other (expense) income :	'	'	'	'
Interest income	7	58	83	196
Interest expense	-1,153	-666	-3,429	-1,329
Gain/recovery of investment	0	0	421	6,957
Other, net	70	23	-324	168
Total other (expense) income, net	-1,076	-585	-3,249	5,992
Income (loss) before income tax	17,698	-6,107	-35,392	-27,517
Income tax expense (benefit)	4,137	5,139	-6,119	-5,104
Net income (loss)	13,561	-11,246	-29,273	-22,413
Net income (loss) per common share:	'	'	'	'
Basic	$0.09	($0.07)	($0.18)	($0.14)
Diluted	$0.08	($0.07)	($0.18)	($0.14)
Common equivalent shares:	'	'	'	'
Basic	157,105	163,838	159,057	165,143
Diluted	163,917	163,838	159,057	165,143
Other comprehensive income (loss):	'	'	'	'
Net unrealized gain on available for sale investments	5	2	3	0
Comprehensive income (loss)	$13,566	($11,244)	($29,270)	($22,413)

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 28, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$26,327	$116,653
Investments in marketable securities	553	22,305
Accounts receivable, net	173,991	132,729
Inventories	175,583	138,246
Prepaid expenses	10,635	8,938
Deferred tax assets, net	12,111	12,530
Other current assets	51,446	48,382
Total current assets	450,646	479,783
Property, plant and equipment, net	454,237	448,741
Goodwill	13,790	4,391
Intangible assets, net	25,001	23,163
Deferred tax assets – noncurrent, net	63,109	57,185
Other noncurrent assets, net	32,062	40,415
Total assets	1,038,845	1,053,678
Current liabilities:	'	'
Accounts payable	77,588	65,388
Accrued payroll	38,182	33,254
Other accrued liabilities	13,721	15,132
Total current liabilities	129,491	113,774
Long-term liabilities:	'	'
Long-term income tax liability	4,070	2,809
Cross-licensing liability	12,027	12,818
Other long-term liabilities	16,699	15,878
Total liabilities	162,287	145,279
Commitments and contingencies (Note 12)	'	'
Stockholders’ equity:	'	'
Preferred Stock, $0.001 par value, 5,000 shares authorized, no shares issued	0	0
Common stock, $0.001 par value, 600,000 shares authorized, 158,263 and 160,611 shares issued and outstanding at September 28, 2013 and December 31, 2012, respectively	158	161
Additional paid-in capital	673,635	676,203
Accumulated other comprehensive loss	-363	-366
Retained earnings	203,128	232,401
Total stockholders’ equity	876,558	908,399
Total liabilities and stockholders’ equity	$1,038,845	$1,053,678

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) (USD $)	Sep. 28, 2013	Dec. 31, 2012
Preferred stock, par value (dollars per share)	$1	$1
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Common stock, par value (dollars per share)	$1	$1
Common stock, shares authorized	600,000,000	600,000,000
Common stock, shares issued	158,263,000	160,611,000
Common stock, shares outstanding	158,263,000	160,611,000

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2013	Sep. 29, 2012
Cash flows from operating activities:	'	'
Net loss	($29,273)	($22,413)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:	'	'
Depreciation and amortization	80,254	69,157
Stock-based compensation charges	21,129	21,619
Deferred income taxes	-7,170	-8,375
Gain/recovery of investment	-421	-6,957
Earnout and milestone liability	-2,009	-916
Other	-201	49
Changes in assets and liabilities:	'	'
Accounts receivable, net	-40,378	6,324
Inventories	-35,605	-2,232
Other assets	-6,013	-35,772
Accounts payable and accrued expenses	18,501	13,891
Net cash (used in) provided by operating activities	-1,186	34,375
Cash flows from investing activities:	'	'
Purchase of available-for-sale investments	-20,940	-64,614
Maturity/sale of available-for-sale investments	42,695	80,429
Proceeds from gain/recovery of investment in other companies	421	6,957
Acquisition of business, net of cash acquired	-5,940	-3,000
Other	885	146
Capital expenditures	-78,032	-45,998
Net cash used in investing activities	-60,911	-26,080
Cash flows from financing activities:	'	'
Subscription/issuance of common stock, net	23,238	14,798
Repurchase of common stock	-51,125	-25,000
Excess tax benefit from stock-based compensation arrangements	-342	0
Net cash used in financing activities	-28,229	-10,202
Net decrease in cash and cash equivalents	-90,326	-1,907
Cash and cash equivalents at beginning of period	116,653	116,305
Cash and cash equivalents at end of period	26,327	114,398
Supplemental disclosures:	'	'
Change in timing of payments related to capital expenditures	2,751	-6,574
Cash paid for income taxes, net of cash refunds	$1,384	$248

Basis_of_Presentation

Basis of Presentation	9 Months Ended
	Sep. 28, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Basis of Presentation	'
	Basis of Presentation
	The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed, or omitted, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In addition, the preparation of financial statements in conformity with GAAP requires management to make estimates and judgments that affect the amounts reported in the financial statements and accompanying notes. For TriQuint Semiconductor, Inc. (the “Company”), the accounting estimates requiring management’s most difficult and subjective judgments include revenue recognition, the valuation of inventory, the accounting for income taxes, precious metals reclaim and stock-based compensation. Certain reclassifications have been made to prior year balances in order to conform to the current year presentation. In the opinion of management, the condensed consolidated financial statements include all material adjustments, consisting only of normal, recurring adjustments, necessary for the fair presentation of the results of the interim periods presented. These condensed consolidated financial statements should be read in conjunction with the audited financial statements of the Company as of and for the fiscal year ended December 31, 2012, included in the Company’s 2012 Annual Report on Form 10-K filed with the SEC on February 26, 2013.

Fair_Value_of_Financial_Instru

Fair Value of Financial Instruments	9 Months Ended
	Sep. 28, 2013
Fair Value Disclosures [Abstract]	'
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The Company accounts for its assets utilizing a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. These two types of inputs have created the following fair-value hierarchy:
	•	Level 1—Quoted prices for identical instruments in active markets;
	•	Level 2—Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and
	•	Level 3—Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
	Assets and liabilities measured and recorded at fair value on a recurring basis at September 28, 2013 are as follows:
			Carrying		Total
			Amount		Fair Value		Cash		Level 1		Level 2		Level 3
	Measured on a recurring basis:
	Assets:
	Cash		$	25,069	$	25,069	$	25,069	$	—	$	—	$	—
	Cash equivalents		1,258		1,258		—		1,258		—		—
	Short-term—marketable securities		553		553		—		—		553		—
	Non-qualified deferred compensation plan		6,049		6,049		—		6,049		—		—
	Total		$	32,929	$	32,929	$	25,069	$	7,307	$	553	$	—
	Liabilities:
	Earnout and milestone payment liability		3,448		3,448		—		—		—		3,448
	Non-qualified deferred compensation plan		6,049		6,049		—		6,049		—		—
	Total		$	9,497	$	9,497	$	—	$	6,049	$	—	$	3,448
	Assets and liabilities measured and recorded at fair value on a recurring basis at December 31, 2012 are as follows:
			Carrying		Total
			Amount		Fair Value		Cash		Level 1		Level 2		Level 3
	Measured on a recurring basis:
	Assets:
	Cash		$	63,104	$	63,104	$	63,104	$	—	$	—	$	—
	Cash equivalents		53,549		53,549		—		53,549		—		—
	Short-term—marketable securities		22,305		22,305		—		4,510		17,795		—
	Non-qualified deferred compensation plan		4,591		4,591		—		4,591		—		—
	Total		$	143,549	$	143,549	$	63,104	$	62,650	$	17,795	$	—
	Liabilities:
	Earnout and milestone payment liability		$	5,457	$	5,457	$	—	$	—	$	—	$	5,457
	Non-qualified deferred compensation plan		4,591		4,591		—		4,591		—		—
	Total		$	10,048	$	10,048	$	—	$	4,591	$	—	$	5,457
	The instruments classified as Level 1 are measured at fair value using quoted market prices. The investments classified as Level 2 were valued using quoted prices for similar instruments in markets that are not active since identical instruments were not available. The Company determines the hierarchy levels at the end of each quarter.
	The Company's non-qualified deferred compensation plan provides eligible employees and members of the Board of Directors with the opportunity to defer a specified percentage of their cash compensation. The Company includes the asset deferred by the participants in the “Other noncurrent assets, net” line item of its consolidated balance sheets and the Company’s obligation to deliver the deferred compensation in the “Other long-term liabilities” line item on its consolidated balance sheets.
	The Company's earnout and milestone payment liability as of September 28, 2013 resulted from two acquisitions during 2012 and represents the fair value of the estimated payout to the former businesses contingent upon meeting certain requirements. For the first acquisition, as of September 28, 2013, the Company estimated the fair value of the obligation as $2,294 using a cash flow based approach discounted with a market discount rate. For the second acquisition, as of September 28, 2013, the Company estimated the fair value of the obligation as $1,154 using a Monte Carlo simulation model discounted using the risk free rate adjusted for an applicable credit spread. During the nine months ended September 28, 2013, the Company remeasured the fair value of the obligation for the second acquisition based on a change in forecast related to the achievement of earnout targets. The change in estimate resulted in a reduction in the liability of $3,371 and was recorded to selling general and administrative expenses in the statement of operations. For both of the acquisitions, total accretion of $1,362 was recognized during the nine months ended September 28, 2013.
	Ending earnout and milestone payment liability at December 31, 2012	$	5,457
	Accretion	1,362
	Change in estimate	(3,371		)
	Ending earnout and milestone payment liability at September 28, 2013	$	3,448
	Financial Instruments Not Recorded at Fair Value on a Recurring Basis
	The Company entered into a cross-licensing agreement in 2012. The fair value of the cross-licensing liability was estimated using a discounted cash flow model which discounts future cash flows using an incremental borrowing rate of 9%. The cross-licensing liability was categorized as Level 3 in the fair value hierarchy and its ending fair value at September 28, 2013 was $15,027, of which $3,000 was current and is included in other current liabilities in the balance sheet.

Recent_Accounting_Pronouncemen

Recent Accounting Pronouncements	9 Months Ended
	Sep. 28, 2013
Accounting Changes and Error Corrections [Abstract]	'
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	In July 2013, the Financial Accounting Standards Board's ("FASB") Emerging Issues Task Force ("EITF") reached final consensus with regard to the "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists." The update is intended to eliminate diversity in practice in the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. Current GAAP does not include explicit guidance on this topic. The main provisions of the update provide that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. An exception exists if such deferred tax asset is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from a disallowance of a tax position or if the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose. In such cases the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The amendments in this update will be applied prospectively. The update is effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. The adoption of this standard will have no net effect on the Company's financial position, results of operations or cash flows. However, once adopted, the standard may change the presentation of unrecognized tax benefits and deferred tax assets in the balance sheet and the income taxes section of the notes to the financial statements.

Investments_in_Cash_Equivalent

Investments in Cash Equivalents and Marketable Securities	9 Months Ended
	Sep. 28, 2013
Investments, Debt and Equity Securities [Abstract]	'
Investments in Cash Equivalents and Marketable Securities	'
	Investments in Cash Equivalents and Marketable Securities
	As of September 28, 2013 and December 31, 2012, all short-term investments were classified as available-for-sale and have maturity dates of less than one year. All unrealized gains and losses on available-for-sale investments are included in other comprehensive loss. The cost, net unrealized holding gains, net unrealized holding losses and fair value of available-for-sale investments by types and classes of security at September 28, 2013 consisted of the following:
	At September 28, 2013	Cost		Net		Net			Fair
				unrealized		unrealized			Value
				holding gains		holding losses
	Available-for-sale-included in cash equivalents:
	Money market funds	$	1,258	$	—	$	—		$	1,258
	Available-for-sale-included in short-term marketable securities:
	Municipal notes	552		1		—			553
		$	1,810	$	1	$	—		$	1,811
	The cost, net unrealized holding gains, net unrealized holding losses and fair value of available-for-sale investments by types and classes of security at December 31, 2012 consisted of the following:
	At December 31, 2012	Cost		Net		Net			Fair
				unrealized		unrealized			Value
				holding gains		holding losses
	Available-for-sale-included in cash equivalents:
	Money market funds and other	$	53,549	$	—	$	—		$	53,549
	Available-for-sale-included in short-term marketable securities:
	U.S. treasury securities	4,510		—		—			4,510
	U.S. government-sponsored enterprise securities	1,065		—		—			1,065
	Corporate debt securities	14,933		—		(3		)	14,930
	Certificates of deposit	1,800		—		—			1,800
		$	75,857	$	—	$	(3	)	$	75,854
	Investments are considered to be impaired when a decline in fair value is judged to be other-than-temporary. The Company employs a methodology that reviews specific securities in evaluating potential impairment of its investments. In the event that the cost of an investment exceeds its fair value, the Company evaluates, among other factors, the Company’s intent and ability to hold the investment and extent to which the fair value is less than cost; the financial health of and business outlook for the issuer; and operating and financing cash flow factors. During the nine months ended September 28, 2013, the Company did not record any other-than-temporary impairments on its investments in cash equivalents or marketable securities.

Net_Loss_Per_Share

Net Loss Per Share	9 Months Ended
	Sep. 28, 2013
Earnings Per Share [Abstract]	'
Net income (loss) per common share:	'
	Net Income (Loss) Per Share
	Net income (loss) per share is presented as basic and diluted net income (loss) per share. Basic net income (loss) per share is net income (loss) available to common stockholders divided by the weighted-average number of common shares outstanding. Diluted net income per share is similar to basic net income (loss) per share, except that the denominator includes potential common shares that, had they been issued, would have had a dilutive effect. Dilutive securities include options granted pursuant to the Company’s stock option plans, and potential shares related to Restricted Stock Units ("RSUs"), Market-Based Restricted Stock Units ("MSUs") and the Company’s Employee Stock Purchase Plan ("ESPP").
	The following is a reconciliation of the basic and diluted shares:
		Three Months Ended					Nine Months Ended
		September 28,		September 29,			September 28,			September 29,
		2013		2012			2013			2012
	Net income (loss):	$	13,561	$	(11,246	)	$	(29,273	)	$	(22,413	)
	Shares for net income (loss) per share:
	Weighted-average shares outstanding—Basic	157,105		163,838			159,057			165,143
	Dilutive securities	6,812		—			—			—
	Weighted-average shares outstanding—Diluted	163,917		163,838			159,057			165,143
	For the three months ended September 28, 2013, securities representing 8,851 potential shares were excluded from the calculation as their effect would have been antidilutive. For the nine months ended September 28, 2013 and the three and nine months ended September 29, 2012 all outstanding options and potential shares related to RSUs, MSUs and the ESPP were excluded from the calculation as their effect would have been antidilutive.

Selected_Financial_Statement_I

Selected Financial Statement Information	9 Months Ended
	Sep. 28, 2013
Selected Financial Statement Information [Abstract]	'
Selected Financial Statement Information [Text Block]	'
	Selected Financial Statement Information
		September 28,			December 31,
		2013			2012
	Accounts receivable, net:
	Trade accounts receivable	$	174,011		$	132,782
	Allowance for doubtful accounts	(20		)	(53		)
		$	173,991		$	132,729
	Inventories:
	Raw materials	$	30,075		$	26,798
	Work-in-process	108,625			72,393
	Finished goods	36,883			39,055
		$	175,583		$	138,246
	Other current assets:
	Precious metals reclaim	$	41,397		$	39,472
	Other	10,049			8,910
		$	51,446		$	48,382
	Accrued payroll:
	Accrued payroll and taxes	$	8,379		$	11,234
	Accrued paid time off and sabbatical	17,220			14,979
	Accrued management incentive program	3,306			2,437
	Self-insurance liability	2,409			2,168
	ESPP Withholdings	6,868			2,436
		$	38,182		$	33,254

Property_Plant_and_Equipment

Property, Plant and Equipment	9 Months Ended
	Sep. 28, 2013
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment	'
	Property, Plant and Equipment
	Property, plant and equipment consisted of the following:
		September 28, 2013			December 31, 2012
	Land	$	19,718		$	19,691
	Buildings	95,080			94,766
	Building and leasehold improvements	32,021			31,012
	Machinery and equipment	755,891			664,737
	Furniture and fixtures	7,007			6,915
	Computer equipment and software	51,742			46,930
	Assets in process	36,542			59,561
	Total property, plant and equipment, gross	998,001			923,612
	Accumulated depreciation	(543,764		)	(474,871		)
	Total property, plant and equipment, net	$	454,237		$	448,741
	The Company reported depreciation expense as follows:
			Three Months Ended					Nine Months Ended
			September 28, 2013			September 29, 2012		September 28, 2013		September 29, 2012
	Depreciation expense		$	26,495		$	22,701	$	74,992	$	64,352

Goodwill_and_Other_Acquisition

Goodwill and Other Acquisition-Related Intangible Assets	9 Months Ended
	Sep. 28, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill and Other Acquisition-Related Intangibles	'
	Goodwill and Other Acquisition-Related Intangible Assets
	The Company is required to perform an impairment analysis on its goodwill at least annually, or when events and circumstances warrant. Conditions that would trigger an impairment assessment, include, but are not limited to, a significant adverse change in legal factors or in the business climate that could affect the value of an asset or an adverse action or assessment by a regulator. The Company is considered one reporting unit. When the Company performed this test in 2012, the Company elected to use the two-step goodwill impairment test. Therefore, to determine whether goodwill may be impaired, the Company compares its book value to its market capitalization. If the trading price of the Company’s common stock, as adjusted for factors such as a control premium, is below the book value per share at the date of the annual impairment test or if the average trading price of the Company’s common stock is below book value per share for a sustained period, a goodwill impairment test will be performed by comparing book value to estimated market value. If the comparison of book value to estimated market value indicates impairment, then the Company compares the estimated market value of goodwill to its carrying amount in a manner similar to a purchase price allocation for a business combination. If the carrying amount of goodwill exceeds its estimated market value, an impairment loss is recognized equal to that excess.
	Unless indicators warrant testing at an earlier date, the Company performs its annual goodwill impairment test in the fourth quarter of each year. During the nine months ended September 28, 2013, there were no impairments recorded.
	Information regarding the Company’s acquisition-related intangible assets is as follows:
				September 28, 2013										December 31, 2012
		Useful		Gross Carrying Amount			Accumulated Amortization				Net Carrying Amount			Gross Carrying Amount			Accumulated Amortization			Net Carrying Amount
		Life
		(Years)
	Goodwill			$	13,790		$	—			$	13,790		$	4,391		$	—		$	4,391
	Amortizing intangible assets
	In process research and development	5-Mar		1,779			(973		)		806			1,779			(658		)	1,121
	Patents, trademarks and other	15-Apr		62,843			(39,498		)		23,345			55,743			(34,551		)	21,192
				64,622			(40,471		)		24,151			57,522			(35,209		)	22,313
	Non-amortizing intangible assets
	In process research and development			850			—				850			850			—			850
	Total intangible assets			65,472			(40,471		)		25,001			58,372			(35,209		)	23,163
	Total goodwill and intangible assets			$	79,262		$	(40,471	)		$	38,791		$	62,763		$	(35,209	)	$	27,554
	Amortizing in process research and development represents acquired research and development assets that have reached technological feasibility. Amortization expense related to intangible assets is as follows:
			Three Months Ended							Nine Months Ended
			September 28,			September 29,				September 28,			September 29,
			2013			2012				2013			2012
	Amortization expense		$	1,730		$	1,649			$	5,262		$	4,805
	The changes in the carrying amount of goodwill and intangible assets are as follows:
			Goodwill and Intangible Assets
			Goodwill			In process research and development- non-amortizing				In process research and development- amortizing			Patents, trademarks and other			Total
	Balance as of December 31, 2012		$	4,391		$	850			$	1,779		$	55,743		$	62,763
	Additions during the period		9,399			—				—			7,100			16,499
	Balance as of September 28, 2013		$	13,790		$	850			$	1,779		$	62,843		$	79,262
	During the third quarter of 2013, the Company completed the acquisition of CAP Wireless ("CAP") a producer of Spatium™ broadband amplifiers, which resulted in the recognition of net tangible assets of $16, and several intangible assets including developed technology for $5,000, customer relationships for $1,500, tradenames for $600, net deferred tax liabilities of $1,665 and goodwill for $9,399. Total consideration of $14,850 was paid with a combination of cash and Company stock. The developed technology, customer relationship and tradename assets will be amortized over a period of 3 to 14 years. The Company has estimated the fair value of the identifiable intangible assets, which are subject to amortization, using a cash flow based approach discounted with a market discount rate. The estimated fair value of these assets is classified as a Level 3 measurement within the fair-value hierarchy. The goodwill is not deductible for tax purposes. The goodwill is calculated as the purchase price in excess of the fair value of assets and liabilities acquired, and represents the Company’s ability to expand its product line into solid state amplifiers, a high margin high growth market currently underserved by the Company. The Company did not have a similar acquisition during the nine months ended September 29, 2012.

Credit_Facility

Credit Facility	9 Months Ended
	Sep. 28, 2013
Line of Credit Facility [Abstract]	'
Credit Facility	'
	On September 30, 2010, the Company, the domestic subsidiaries of the Company (the “Guarantors”), Bank of America, N.A., as administrative agent and lender, and Union Bank, N.A., Wells Fargo Bank, N.A., Bank of the West, BBVA Compass Bank and US Bank, as lenders (together with the administrative agent, the “Lenders”), entered into a Credit Agreement (the “Agreement”). The Agreement provides the Company with a three-year unsecured revolving syndicated credit facility of $200,000 maturing on September 30, 2013. On August 24, 2011, the Company extended, with the Lenders' consent, the maturity date to September 30, 2014. The Company’s obligations under the Agreement are jointly and severally guaranteed by the Guarantors. Upon the occurrence of certain events of default specified in the Agreement, amounts due under the Agreement may be declared immediately due and payable.
	The Company may elect to borrow at either a Eurodollar Rate or a Base Rate (each as defined in the Agreement). Eurodollar Rate loans bear interest at an amount equal to the sum of a rate per annum calculated from the British Bankers Association London Interbank Offered Rate ("LIBOR") plus a designated percentage per annum (the “Applicable Rate”). The Applicable Rate for Eurodollar Rate loans is based on the Company’s consolidated total leverage ratio (as defined in the Agreement) and is subject to a floor of 2.50% per annum and a cap of 3.00% per annum. Base Rate loans bear interest at a rate equal to the higher of the federal funds rate plus 0.50%, the prime rate of Bank of America, N.A. plus the Applicable Rate or the Eurodollar Base Rate plus 1.0%. The Applicable Rate for Base Rate loans is subject to a floor of 1.50% per annum and a cap of 2.00% per annum. The interest payment date (as defined in the Agreement) will vary based on the type of loan but generally will be quarterly. The Company paid commitment fees, an arrangement fee, upfront fees and a renewal fee pursuant to the terms of the Agreement. The Company will also pay a quarterly fee for any letters of credit issued under the Agreement. The initial fees associated with the Agreement were capitalized and are being amortized to interest expense using the straight-line method over the remaining term to maturity.
	The Agreement contains non-financial covenants of the Company and the Guarantors, including restrictions on the ability to create, incur or assume liens and other debt, make certain investments, dispositions and restricted payments, change the nature of the business, and merge with other entities subject to certain caps as defined in the agreement. The Agreement requires the Company to maintain ratios defined in the Agreement, which include a consolidated total leverage ratio as of the end of any fiscal quarter not in excess of 2.50 to 1.00, a consolidated liquidity ratio of at least 1.25 to 1.00 and a consolidated interest coverage ratio at a minimum of 3.00 to 1.00. The Company was in compliance with these covenants as of September 28, 2013.
	At September 28, 2013 and December 31, 2012 there were no amounts outstanding under the Agreement. During the three and nine months ended September 28, 2013, the average outstanding balance under the Agreement was $12,967 and $4,502, respectively. During the three and nine months ended September 28, 2013, interest cost of $118 and $121, respectively, was incurred on borrowings. No interest cost was incurred on borrowings during the three or nine months ended September 29, 2012.

StockBased_Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 28, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Stock-based Compensation	'
	Stock-Based Compensation
	Stock-based compensation expense consists of compensation costs related to grants of stock options, RSUs, MSUs and the ESPP. The table below summarizes the stock-based compensation expense for the three and nine months ended September 28, 2013 and September 29, 2012:
			Three Months Ended							Nine Months Ended
			September 28,				September 29,			September 28,		September 29,
			2013				2012			2013		2012
	Stock-based compensation expense:
	Cost of goods sold		$	1,720			$	2,549		$	5,327	$	6,477
	Research, development and engineering		2,802				2,226			7,897		6,914
	Selling, general and administrative		2,391				2,589			7,905		8,228
	Total stock-based compensation expense included in net income (loss) from operations		$	6,913			$	7,364		$	21,129	$	21,619
	Stock Options
	The following table summarizes the Company’s stock option transactions for the nine months ended September 28, 2013:
			Nine Months Ended
			September 28, 2013
			Shares			Weighted-average exercise price per share
	Outstanding at December 31, 2012		33,241			$	6.56
	Granted		7,015			5.86
	Exercised		(2,435	)		4.59
	Forfeited		(1,190	)		7.27
	Outstanding at September 28, 2013		36,631			$	6.53
	Restricted Stock Units
	During the three and nine months ended September 28, 2013, the Company granted RSUs to non-executive employees under the stockholder approved 2013 Incentive Plan. RSUs are converted into shares of Company common stock upon vesting on a one-for-one basis. The awards typically vest over four years and vesting is subject to the grantee’s continued service with the Company. In the event of a Change in Control, all outstanding RSUs will become fully vested. The compensation expense related to the service-based RSU awards is determined using the fair market value of Company common stock on the date of the grant, and the compensation expense, reduced by estimated forfeitures, is recognized over the vesting period.
	The following table summarizes RSU activity during nine months ended September 28, 2013:
			Nine Months Ended
			28-Sep-13
			Shares			Weighted-average exercise price per share
	Outstanding at December 31, 2012		—			—
	Granted		100			$	7.76
	Outstanding at September 28, 2013		100			$	7.76
	Market-Based Restricted Stock Units
	During the nine months ended September 28, 2013, the Company granted MSUs to certain members of executive management. The number of shares that are ultimately awarded is contingent upon the achievement of pre-determined market and service conditions. Market conditions must be met for shares to be awarded, even if the service conditions are met. Fair value of the awards is determined at the grant date based on the target number of awards ultimately expected to be awarded. Compensation expense associated with the awards is calculated based on the target number of shares ultimately expected to be awarded and is recognized on a straight line basis over the requisite service period and will not be reversed even if the market conditions are not met. The number of shares of common stock to be awarded will range from zero to 150 percent of the target number of stock units based on the Company's total stockholder return (“TSR”) relative to the performance of companies in the SPDR S&P Semiconductor Index ("SPDR") for each measurement period. TSR is calculated based on market performance between the beginning and end of the award period, generally over three years. Based on the number of awards outstanding during the three and nine months ended September 28, 2013, the maximum number of shares of common stock that could be awarded is 299 shares.
	The fair value of the MSUs was determined using a Monte Carlo simulation model. The Monte Carlo simulation model is affected by assumptions regarding subjective and complex variables. Generally, the Company's assumptions are based on historical information and judgment is required to determine if historical trends may be indicators of future outcomes. Key assumptions for the Monte Carlo simulation model were as follows:
		Three Months Ended						Nine Months Ended
		September 28,			September 29,			September 28,		September 29,
		2013			2012			2013		2012
	Risk free interest rates	0.4	%		—			0.4	%	—
	Expected dividend yield	—			—			—		—
	Expected volatility	56.2	%		—			56.2	%	—
	Correlation coefficient to SPDR	0.59			—			0.59		—
	In the following table, MSU activity during the nine months ended September 28, 2013 is presented at 100 percent of the target number of shares of common stock that may potentially be awarded:
			Nine Months Ended
			September 28, 2013
			Shares			Weighted-average grant date fair value
	Outstanding at December 31, 2012		—			$	—
	Granted		199			7.45
	Outstanding at September 28, 2013		199			$	7.45
	ESPP
	Employees participating in the ESPP authorize the Company to withhold compensation and to use the withheld amounts to purchase shares of the Company's common stock at a discount.
	The table below summarizes the ESPP common stock purchases for the three and nine months ended September 28, 2013 and September 29, 2012.
			Three Months Ended						Nine Months Ended
			September 28,			September 29,			September 28,		September 29,
			2013			2012			2013		2012
	Shares purchased		—			—			1,872		1,770

Income_Taxes

Income Taxes	9 Months Ended
	Sep. 28, 2013
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Income Taxes
	The Company recorded income tax expense of $4,137 and an income tax benefit of $6,119 for the three and nine months ended September 28, 2013, respectively. For the three and nine months ended September 29, 2012, the Company recorded income tax expense of $5,139 and an income tax benefit of $5,104, respectively. The income tax expense for the three months ended September 28, 2013 was primarily associated with U.S. federal and state income taxes due to the mix of profits and losses between jurisdictions. The income tax benefit for the nine months ended September 28, 2013 was primarily the result of the Company's pre-tax loss, the recognition of U.S. federal tax credits, and equity compensation deductions. The income tax expense for the three months ended September 29, 2012 was primarily associated with U.S. federal and state income taxes due to the mix of profits and losses between jurisdictions and the recognition of additional valuation allowance. The income tax benefit for the nine months ended September 29, 2012 was primarily associated with the Company's pre-tax loss offset by an accrual for unrecognized tax benefits and the recognition of additional valuation allowance.
	In January 2013, the American Taxpayer Relief Act of 2012 was signed into law, retroactively reinstating the Research and Experimental ("R&E") tax credit for 2012 and through 2013. The expected benefit for 2012 of approximately $4,045 was recorded during the three months ended March 30, 2013.
	No provision has been made for U.S., state or additional foreign income taxes related to approximately $104,497 of undistributed earnings of foreign subsidiaries which have been permanently reinvested outside of the United States, except for liquidating foreign entities and existing earnings that have been previously taxed. It is not practicable to determine the U.S. federal income tax liability, if any, which would be payable if such earnings were not permanently reinvested outside of the United States. In the event the foreign subsidiaries repatriate these earnings, which would generally require board approval, the earnings may be subject to additional U.S. federal and state income taxes and foreign withholding taxes. The additional taxes could be partially offset by net operating losses and/or foreign tax credits.
	The major jurisdictions in which the Company files tax returns are the United States, Singapore and Costa Rica. In 2012, the Company expanded its presence into Asia by increasing operations in Singapore. Tax years beginning in 2006 are subject to examination by taxing authorities, although net operating losses ("NOL") and credit carryforwards from all years are subject to examinations and adjustments for at least three years following the year in which the attributes are used.
	Due to agreements with the Costa Rican and Singaporean governments, the Company was granted income tax holidays of varying rates through March 2017 and December 2019, respectively. Incentives from these countries are subject to the Company meeting certain employment and investment requirements. The Company was in compliance with these requirements as of September 28, 2013.
	Deferred Income Taxes
	As of September 28, 2013, deferred tax assets of $75,220, net of a $15,558 valuation allowance, were recorded on the balance sheet. As of December 31, 2012, the Company recorded deferred tax assets of $69,715, net of a $14,518 valuation allowance. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more-likely-than-not to be realized. The Company maintains a valuation allowance against the tax effect of certain state and foreign net operating loss carryforwards and certain state credit carryforwards, as management does not believe it is more likely than not that these benefits will be realized in future periods.
	Unrecognized Tax Benefits
	In the nine months ended September 28, 2013, net unrecognized tax benefits increased $1,261 primarily as a result of an additional liability recorded to address existing potential exposures involving positions that could be challenged by taxing authorities. The Company does not anticipate the release of any unrecognized tax benefits due to the expiration of statutes of limitations within the next twelve months. Interest and penalties associated with unrecognized tax benefits are accrued and classified as a component of tax expense in the statement of operations and comprehensive loss.
	Net unrecognized tax benefits at September 28, 2013 and December 31, 2012 were as follows:
		September 28,		December 31,
		2013		2012
	Net unrecognized tax benefits	$	4,070	$	2,809

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 28, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	Commitments and Contingencies
	Legal Matters
	The Company is from time to time involved in litigation, certain other claims and arbitration matters arising in the ordinary course of its business. The Company accrues for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated.  Significant judgment is required in both the determination of the probability of a loss and the determination as to whether a loss is reasonably estimable. These accruals are reviewed at least quarterly and adjusted to reflect the effects of negotiations, settlements, rulings, advice of legal counsel and technical experts and other information and events pertaining to a particular matter.  To the extent there is a reasonable possibility (within the meaning of FASB Accounting Standards Codification ("ASC") 450) that losses could exceed amounts already accrued, if any, and the additional loss or range of loss is able to be estimated, management discloses the additional loss or range of loss.
	In some instances, the Company is unable to reasonably estimate any potential loss or range of loss. The nature and progression of litigation can make it difficult to predict the impact a particular lawsuit will have on the Company.  There are many reasons that the Company cannot make these assessments, including, among others, one or more of the following:  the early stages of a proceeding; damages sought that are unspecified, unsupportable, unexplained or uncertain; discovery not having been started or incomplete; the complexity of the facts that are in dispute; the difficulty of assessing novel claims; the parties not having engaged in any meaningful settlement discussions; the possibility that other parties may share in any ultimate liability; and/or the often slow pace of litigation.

Investment_in_CyOptics_Inc

Investment in CyOptics, Inc.	9 Months Ended
	Sep. 28, 2013
Cost-method Investments, Realized Gain (Loss), Alternative [Abstract]	'
Investment in CyOptics, Inc.	'
	Investment in CyOptics, Inc.
	In previous years, the Company made a number of investments in small, privately held technology companies in which the Company has held less than 20% of the capital stock or held notes receivable. As a result of the sale of the Company's former optoelectronics operations, the Company received as partial consideration $4,500 of preferred stock and an unsecured promissory note from CyOptics Inc. ("CyOptics") for $5,633. In years prior to 2012, the carrying amount of the CyOptics investment was fully impaired and written down to $0. During the nine months ended September 29, 2012, the remaining amount due on the promissory note was settled in full and the preferred stock was sold in exchange for an initial liquidation payment of $6,957 and an escrow holdback contingent upon certain conditions. The initial liquidation payment was received in cash in March, 2012. The final liquidation payment of $421 from the escrow holdback account was received in cash in May, 2013. Both of the liquidation transactions were recorded as a gain/recovery of investment in the statement of operations and in the operating activities section of the statement of cash flows. The cash proceeds from both of the payments were included in the investing activities section of the statement of cash flows.

Stock_Repurchase_Program_Stock

Stock Repurchase Program Stock Repurchase Program (Notes)	9 Months Ended
	Sep. 28, 2013
Payments for Repurchase of Equity [Abstract]	'
Stock Repurchase [Text Block]	'
	Stock Repurchase Program
	On May 13, 2013, the Company's Board of Directors approved a stock repurchase program authorizing the purchase, at the discretion of management, of up to $75,000 of the Company's outstanding common stock. Common stock repurchases may be made from time to time in the open market at prevailing market prices or through privately negotiated transactions. The timing of open market and privately negotiated purchases will be dependent upon market conditions and other corporate considerations, including price, corporate and regulatory requirements and alternative investment opportunities. The Company expects to use available cash to fund the repurchase program. Shares of common stock repurchased by the Company through the repurchase program will be retired and will have no impact on total shares authorized.
	During the nine months ended September 28, 2013 and September 29, 2012, the Company repurchased 7,670 and 4,879 shares for $51,125 and $25,000, respectively, using available cash.

Subsequent_Events_Subsequent_E

Subsequent Events Subsequent Events (Notes)	9 Months Ended
	Sep. 28, 2013
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	Subsequent Events
	On October 14, 2013, management approved plans to dispose of assets relating to a reduction of gallium arsenide ("GaAs") capacity. In the fourth quarter of 2013, the Company will record a loss on disposal for the difference between the carry value of the assets and proceeds upon disposal, less costs to sell. The loss is expected to be between $20,000 and $25,000.

Basis_of_Presentation_Policies

Basis of Presentation (Policies)	9 Months Ended
	Sep. 28, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Use of Estimates	'
	In addition, the preparation of financial statements in conformity with GAAP requires management to make estimates and judgments that affect the amounts reported in the financial statements and accompanying notes. For TriQuint Semiconductor, Inc. (the “Company”), the accounting estimates requiring management’s most difficult and subjective judgments include revenue recognition, the valuation of inventory, the accounting for income taxes, precious metals reclaim and stock-based compensation.
Fair Value Policy	'
	The Company accounts for its assets utilizing a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. These two types of inputs have created the following fair-value hierarchy:
	•	Level 1—Quoted prices for identical instruments in active markets;
	•	Level 2—Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and
	•	Level 3—Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
	The instruments classified as Level 1 are measured at fair value using quoted market prices. The investments classified as Level 2 were valued using quoted prices for similar instruments in markets that are not active since identical instruments were not available. The Company determines the hierarchy levels at the end of each quarter.
Marketable Securities Policy	'
	All unrealized gains and losses on available-for-sale investments are included in other comprehensive loss.
Earnings Per Share Policy	'
	Net income (loss) per share is presented as basic and diluted net income (loss) per share. Basic net income (loss) per share is net income (loss) available to common stockholders divided by the weighted-average number of common shares outstanding. Diluted net income per share is similar to basic net income (loss) per share, except that the denominator includes potential common shares that, had they been issued, would have had a dilutive effect.
Goodwill and Intangible Assets Policy	'
	The Company is required to perform an impairment analysis on its goodwill at least annually, or when events and circumstances warrant. Conditions that would trigger an impairment assessment, include, but are not limited to, a significant adverse change in legal factors or in the business climate that could affect the value of an asset or an adverse action or assessment by a regulator. The Company is considered one reporting unit. When the Company performed this test in 2012, the Company elected to use the two-step goodwill impairment test. Therefore, to determine whether goodwill may be impaired, the Company compares its book value to its market capitalization. If the trading price of the Company’s common stock, as adjusted for factors such as a control premium, is below the book value per share at the date of the annual impairment test or if the average trading price of the Company’s common stock is below book value per share for a sustained period, a goodwill impairment test will be performed by comparing book value to estimated market value. If the comparison of book value to estimated market value indicates impairment, then the Company compares the estimated market value of goodwill to its carrying amount in a manner similar to a purchase price allocation for a business combination. If the carrying amount of goodwill exceeds its estimated market value, an impairment loss is recognized equal to that excess.
	Unless indicators warrant testing at an earlier date, the Company performs its annual goodwill impairment test in the fourth quarter of each year. During the nine months ended September 28, 2013, there were no impairments recorded.
Amortization of Loan Fees	'
	The initial fees associated with the Agreement were capitalized and are being amortized to interest expense using the straight-line method over the remaining term to maturity.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	'
	Market-Based Restricted Stock Units
	During the nine months ended September 28, 2013, the Company granted MSUs to certain members of executive management. The number of shares that are ultimately awarded is contingent upon the achievement of pre-determined market and service conditions. Market conditions must be met for shares to be awarded, even if the service conditions are met. Fair value of the awards is determined at the grant date based on the target number of awards ultimately expected to be awarded. Compensation expense associated with the awards is calculated based on the target number of shares ultimately expected to be awarded and is recognized on a straight line basis over the requisite service period and will not be reversed even if the market conditions are not met. The number of shares of common stock to be awarded will range from zero to 150 percent of the target number of stock units based on the Company's total stockholder return (“TSR”) relative to the performance of companies in the SPDR S&P Semiconductor Index ("SPDR") for each measurement period. TSR is calculated based on market performance between the beginning and end of the award period, generally over three years.
	Restricted Stock Units
	During the three and nine months ended September 28, 2013, the Company granted RSUs to non-executive employees under the stockholder approved 2013 Incentive Plan. RSUs are converted into shares of Company common stock upon vesting on a one-for-one basis. The awards typically vest over four years and vesting is subject to the grantee’s continued service with the Company. In the event of a Change in Control, all outstanding RSUs will become fully vested. The compensation expense related to the service-based RSU awards is determined using the fair market value of Company common stock on the date of the grant, and the compensation expense, reduced by estimated forfeitures, is recognized over the vesting period.
Commitments and Contingencies, Policy [Policy Text Block]	'
	Legal Matters
	The Company is from time to time involved in litigation, certain other claims and arbitration matters arising in the ordinary course of its business. The Company accrues for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated.  Significant judgment is required in both the determination of the probability of a loss and the determination as to whether a loss is reasonably estimable. These accruals are reviewed at least quarterly and adjusted to reflect the effects of negotiations, settlements, rulings, advice of legal counsel and technical experts and other information and events pertaining to a particular matter.  To the extent there is a reasonable possibility (within the meaning of FASB Accounting Standards Codification ("ASC") 450) that losses could exceed amounts already accrued, if any, and the additional loss or range of loss is able to be estimated, management discloses the additional loss or range of loss.

Fair_Value_of_Financial_Instru1

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 28, 2013
Fair Value Disclosures [Abstract]	'
Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table	'
	Assets and liabilities measured and recorded at fair value on a recurring basis at September 28, 2013 are as follows:
			Carrying		Total
			Amount		Fair Value		Cash		Level 1		Level 2		Level 3
	Measured on a recurring basis:
	Assets:
	Cash		$	25,069	$	25,069	$	25,069	$	—	$	—	$	—
	Cash equivalents		1,258		1,258		—		1,258		—		—
	Short-term—marketable securities		553		553		—		—		553		—
	Non-qualified deferred compensation plan		6,049		6,049		—		6,049		—		—
	Total		$	32,929	$	32,929	$	25,069	$	7,307	$	553	$	—
	Liabilities:
	Earnout and milestone payment liability		3,448		3,448		—		—		—		3,448
	Non-qualified deferred compensation plan		6,049		6,049		—		6,049		—		—
	Total		$	9,497	$	9,497	$	—	$	6,049	$	—	$	3,448
	Assets and liabilities measured and recorded at fair value on a recurring basis at December 31, 2012 are as follows:
			Carrying		Total
			Amount		Fair Value		Cash		Level 1		Level 2		Level 3
	Measured on a recurring basis:
	Assets:
	Cash		$	63,104	$	63,104	$	63,104	$	—	$	—	$	—
	Cash equivalents		53,549		53,549		—		53,549		—		—
	Short-term—marketable securities		22,305		22,305		—		4,510		17,795		—
	Non-qualified deferred compensation plan		4,591		4,591		—		4,591		—		—
	Total		$	143,549	$	143,549	$	63,104	$	62,650	$	17,795	$	—
	Liabilities:
	Earnout and milestone payment liability		$	5,457	$	5,457	$	—	$	—	$	—	$	5,457
	Non-qualified deferred compensation plan		4,591		4,591		—		4,591		—		—
	Total		$	10,048	$	10,048	$	—	$	4,591	$	—	$	5,457
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation	'
	Ending earnout and milestone payment liability at December 31, 2012	$	5,457
	Accretion	1,362
	Change in estimate	(3,371		)
	Ending earnout and milestone payment liability at September 28, 2013	$	3,448

Investments_in_Cash_Equivalent1

Investments in Cash Equivalents and Marketable Securities (Tables)	9 Months Ended
	Sep. 28, 2013
Investments, Debt and Equity Securities [Abstract]	'
Available-for-sale Securities	'
	The cost, net unrealized holding gains, net unrealized holding losses and fair value of available-for-sale investments by types and classes of security at September 28, 2013 consisted of the following:
	At September 28, 2013	Cost		Net		Net			Fair
				unrealized		unrealized			Value
				holding gains		holding losses
	Available-for-sale-included in cash equivalents:
	Money market funds	$	1,258	$	—	$	—		$	1,258
	Available-for-sale-included in short-term marketable securities:
	Municipal notes	552		1		—			553
		$	1,810	$	1	$	—		$	1,811
	The cost, net unrealized holding gains, net unrealized holding losses and fair value of available-for-sale investments by types and classes of security at December 31, 2012 consisted of the following:
	At December 31, 2012	Cost		Net		Net			Fair
				unrealized		unrealized			Value
				holding gains		holding losses
	Available-for-sale-included in cash equivalents:
	Money market funds and other	$	53,549	$	—	$	—		$	53,549
	Available-for-sale-included in short-term marketable securities:
	U.S. treasury securities	4,510		—		—			4,510
	U.S. government-sponsored enterprise securities	1,065		—		—			1,065
	Corporate debt securities	14,933		—		(3		)	14,930
	Certificates of deposit	1,800		—		—			1,800
		$	75,857	$	—	$	(3	)	$	75,854

Net_Loss_Per_Share_Earnings_Pe

Net Loss Per Share Earnings Per Share (Tables)	9 Months Ended
	Sep. 28, 2013
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'
	The following is a reconciliation of the basic and diluted shares:
		Three Months Ended					Nine Months Ended
		September 28,		September 29,			September 28,			September 29,
		2013		2012			2013			2012
	Net income (loss):	$	13,561	$	(11,246	)	$	(29,273	)	$	(22,413	)
	Shares for net income (loss) per share:
	Weighted-average shares outstanding—Basic	157,105		163,838			159,057			165,143
	Dilutive securities	6,812		—			—			—
	Weighted-average shares outstanding—Diluted	163,917		163,838			159,057			165,143
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	'
	For the three months ended September 28, 2013, securities representing 8,851 potential shares were excluded from the calculation as their effect would have been antidilutive. For the nine months ended September 28, 2013 and the three and nine months ended September 29, 2012 all outstanding options and potential shares related to RSUs, MSUs and the ESPP were excluded from the calculation as their effect would have been antidilutive.

Selected_Financial_Statement_I1

Selected Financial Statement Information (Tables)	9 Months Ended
	Sep. 28, 2013
Selected Financial Statement Information [Abstract]	'
Selected Financial Statement Information [Table Text Block]	'
		September 28,			December 31,
		2013			2012
	Accounts receivable, net:
	Trade accounts receivable	$	174,011		$	132,782
	Allowance for doubtful accounts	(20		)	(53		)
		$	173,991		$	132,729
	Inventories:
	Raw materials	$	30,075		$	26,798
	Work-in-process	108,625			72,393
	Finished goods	36,883			39,055
		$	175,583		$	138,246
	Other current assets:
	Precious metals reclaim	$	41,397		$	39,472
	Other	10,049			8,910
		$	51,446		$	48,382
	Accrued payroll:
	Accrued payroll and taxes	$	8,379		$	11,234
	Accrued paid time off and sabbatical	17,220			14,979
	Accrued management incentive program	3,306			2,437
	Self-insurance liability	2,409			2,168
	ESPP Withholdings	6,868			2,436
		$	38,182		$	33,254

Property_Plant_and_Equipment_T

Property, Plant and Equipment (Tables)	9 Months Ended
	Sep. 28, 2013
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment	'
	Property, plant and equipment consisted of the following:
		September 28, 2013			December 31, 2012
	Land	$	19,718		$	19,691
	Buildings	95,080			94,766
	Building and leasehold improvements	32,021			31,012
	Machinery and equipment	755,891			664,737
	Furniture and fixtures	7,007			6,915
	Computer equipment and software	51,742			46,930
	Assets in process	36,542			59,561
	Total property, plant and equipment, gross	998,001			923,612
	Accumulated depreciation	(543,764		)	(474,871		)
	Total property, plant and equipment, net	$	454,237		$	448,741
Schedule of Depreciation Expense	'
	The Company reported depreciation expense as follows:
			Three Months Ended					Nine Months Ended
			September 28, 2013			September 29, 2012		September 28, 2013		September 29, 2012
	Depreciation expense		$	26,495		$	22,701	$	74,992	$	64,352

Goodwill_and_Other_Acquisition1

Goodwill and Other Acquisition-Related Intangible Assets (Tables)	9 Months Ended
	Sep. 28, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Changes in Gross Goodwill and Intangibles	'
	The changes in the carrying amount of goodwill and intangible assets are as follows:
			Goodwill and Intangible Assets
			Goodwill			In process research and development- non-amortizing				In process research and development- amortizing			Patents, trademarks and other			Total
	Balance as of December 31, 2012		$	4,391		$	850			$	1,779		$	55,743		$	62,763
	Additions during the period		9,399			—				—			7,100			16,499
	Balance as of September 28, 2013		$	13,790		$	850			$	1,779		$	62,843		$	79,262
Schedule of Intangible Assets and Goodwill	'
	Information regarding the Company’s acquisition-related intangible assets is as follows:
				September 28, 2013										December 31, 2012
		Useful		Gross Carrying Amount			Accumulated Amortization				Net Carrying Amount			Gross Carrying Amount			Accumulated Amortization			Net Carrying Amount
		Life
		(Years)
	Goodwill			$	13,790		$	—			$	13,790		$	4,391		$	—		$	4,391
	Amortizing intangible assets
	In process research and development	5-Mar		1,779			(973		)		806			1,779			(658		)	1,121
	Patents, trademarks and other	15-Apr		62,843			(39,498		)		23,345			55,743			(34,551		)	21,192
				64,622			(40,471		)		24,151			57,522			(35,209		)	22,313
	Non-amortizing intangible assets
	In process research and development			850			—				850			850			—			850
	Total intangible assets			65,472			(40,471		)		25,001			58,372			(35,209		)	23,163
	Total goodwill and intangible assets			$	79,262		$	(40,471	)		$	38,791		$	62,763		$	(35,209	)	$	27,554
Schedule of Intangible Asset Amortization	'
	Amortization expense related to intangible assets is as follows:
			Three Months Ended							Nine Months Ended
			September 28,			September 29,				September 28,			September 29,
			2013			2012				2013			2012
	Amortization expense		$	1,730		$	1,649			$	5,262		$	4,805

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 28, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]	'
	The following table summarizes RSU activity during nine months ended September 28, 2013:
			Nine Months Ended
			28-Sep-13
			Shares			Weighted-average exercise price per share
	Outstanding at December 31, 2012		—			—
	Granted		100			$	7.76
	Outstanding at September 28, 2013		100			$	7.76
Schedule of Stock-Based Compensation	'
	The table below summarizes the stock-based compensation expense for the three and nine months ended September 28, 2013 and September 29, 2012:
			Three Months Ended							Nine Months Ended
			September 28,				September 29,			September 28,		September 29,
			2013				2012			2013		2012
	Stock-based compensation expense:
	Cost of goods sold		$	1,720			$	2,549		$	5,327	$	6,477
	Research, development and engineering		2,802				2,226			7,897		6,914
	Selling, general and administrative		2,391				2,589			7,905		8,228
	Total stock-based compensation expense included in net income (loss) from operations		$	6,913			$	7,364		$	21,129	$	21,619
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
	The following table summarizes the Company’s stock option transactions for the nine months ended September 28, 2013:
			Nine Months Ended
			September 28, 2013
			Shares			Weighted-average exercise price per share
	Outstanding at December 31, 2012		33,241			$	6.56
	Granted		7,015			5.86
	Exercised		(2,435	)		4.59
	Forfeited		(1,190	)		7.27
	Outstanding at September 28, 2013		36,631			$	6.53
Schedule of assumptions used in monte-carlo simulation model [Table Text Block]	'
	Key assumptions for the Monte Carlo simulation model were as follows:
		Three Months Ended						Nine Months Ended
		September 28,			September 29,			September 28,		September 29,
		2013			2012			2013		2012
	Risk free interest rates	0.4	%		—			0.4	%	—
	Expected dividend yield	—			—			—		—
	Expected volatility	56.2	%		—			56.2	%	—
	Correlation coefficient to SPDR	0.59			—			0.59		—
Schedule of Share-based Compensation, Market-based Restricted Stock Units, Activity [Table Text Block]	'
	In the following table, MSU activity during the nine months ended September 28, 2013 is presented at 100 percent of the target number of shares of common stock that may potentially be awarded:
			Nine Months Ended
			September 28, 2013
			Shares			Weighted-average grant date fair value
	Outstanding at December 31, 2012		—			$	—
	Granted		199			7.45
	Outstanding at September 28, 2013		199			$	7.45
Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]	'
	The table below summarizes the ESPP common stock purchases for the three and nine months ended September 28, 2013 and September 29, 2012.
			Three Months Ended						Nine Months Ended
			September 28,			September 29,			September 28,		September 29,
			2013			2012			2013		2012
	Shares purchased		—			—			1,872		1,770

Income_Taxes_Tables

Income Taxes (Tables)	9 Months Ended
	Sep. 28, 2013
Income Tax Disclosure [Abstract]	'
Schedule of Unrecognized Tax Benefits	'
	Net unrecognized tax benefits at September 28, 2013 and December 31, 2012 were as follows:
		September 28,		December 31,
		2013		2012
	Net unrecognized tax benefits	$	4,070	$	2,809

Fair_Value_of_Financial_Instru2

Fair Value of Financial Instruments (Details) (USD $)	Sep. 28, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Assets:	'	'
Cash	$25,069	$63,104
Cash equivalents	1,258	53,549
Short-term—marketable securities	553	22,305
Non-qualified deferred compensation plan	6,049	4,591
Total	32,929	143,549
Short-term—marketable securities	1,811	75,854
Liabilities:	'	'
Earnout and milestone payment liability	3,448	5,457
Non-qualified deferred compensation plan	6,049	4,591
Total	9,497	10,048
Level 1 | Fair Value, Measurements, Recurring [Member]	'	'
Assets:	'	'
Cash	0	0
Cash equivalents	1,258	53,549
Short-term—marketable securities	0	4,510
Non-qualified deferred compensation plan	6,049	4,591
Total	7,307	62,650
Liabilities:	'	'
Earnout payment liability	0	0
Non-qualified deferred compensation plan	6,049	4,591
Total	6,049	4,591
Level 2 | Fair Value, Measurements, Recurring [Member]	'	'
Assets:	'	'
Cash	0	0
Cash equivalents	0	0
Short-term—marketable securities	553	17,795
Non-qualified deferred compensation plan	0	0
Total	553	17,795
Liabilities:	'	'
Earnout payment liability	0	0
Non-qualified deferred compensation plan	0	0
Total	0	0
Level 3 | Fair Value, Measurements, Recurring [Member]	'	'
Assets:	'	'
Cash	'	0
Cash equivalents	0	0
Short-term—marketable securities	0	0
Non-qualified deferred compensation plan	0	0
Total	0	0
Liabilities:	'	'
Earnout payment liability	3,448	5,457
Non-qualified deferred compensation plan	0	0
Total	3,448	5,457
Estimate of Fair Value Measurement [Member] | Fair Value, Measurements, Recurring [Member]	'	'
Assets:	'	'
Cash	25,069	63,104
Cash equivalents	1,258	53,549
Short-term—marketable securities	553	22,305
Non-qualified deferred compensation plan	6,049	4,591
Total	32,929	143,549
Liabilities:	'	'
Earnout payment liability	3,448	5,457
Non-qualified deferred compensation plan	6,049	4,591
Total	$9,497	$10,048

Fair_Value_of_Financial_Instru3

Fair Value of Financial Instruments - Earnout Payment Liability (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2013
Earnout and Milestone Payment Liability [Member]	'
Details of Level 3 fair value measurements	'
Ending earnout and milestone payment liability at December 31, 2012	$5,457
Accretion	1,362
Change in estimate	-3,371
Ending earnout and milestone payment liability at September 28, 2013	3,448
Estimate of Fair Value, Fair Value Disclosure [Member] | Fair Value, Measurements, Recurring [Member] | Level 3 | First 2012 Acquisition [Member]	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'
Business Combination, Contingent Consideration, Liability	2,294
Estimate of Fair Value, Fair Value Disclosure [Member] | Fair Value, Measurements, Recurring [Member] | Level 3 | Second 2012 Acquisition [Member]	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'
Business Combination, Contingent Consideration, Liability	$1,154

Fair_Value_of_Financial_Instru4

Fair Value of Financial Instruments - Cross Licensing Liability (Details) (Level 3, Fair Value, Measurements, Nonrecurring [Member], Estimate of Fair Value, Fair Value Disclosure [Member], USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2013
Level 3 | Fair Value, Measurements, Nonrecurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'
Incremental borrowing rate	9.00%
Cross-licensing liability	$15,027
Cross-licensing Liability, Fair Value Disclosure, Current Portion	$3,000

Investments_in_Cash_Equivalent2

Investments in Cash Equivalents and Marketable Securities (Details) (USD $)	9 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2013	Dec. 31, 2012
Schedule of Available-for-sale Securities [Line Items]	'	'
Available-for-sale Securities, Amortized Cost Basis	$1,810	$75,857
Available For Sale Securities Net Unrealized Gains	1	0
Available For Sale Securities Net Unrealized Losses	0	-3
Available-for-sale Securities	1,811	75,854
Maximum Term Of Available For Sale Securities	'1 year	'1 year
Marketable Securities, Realized Loss, Other than Temporary Impairments, Amount	0	'
Cash Equivalents [Member] | Money Market Funds [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Available-for-sale Securities, Amortized Cost Basis	1,258	53,549
Available For Sale Securities Net Unrealized Gains	0	0
Available For Sale Securities Net Unrealized Losses	0	0
Available-for-sale Securities	1,258	53,549
Short Term Marketable Securities [Member] | Corporate Debt Securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Available-for-sale Securities, Amortized Cost Basis	'	14,933
Available For Sale Securities Net Unrealized Gains	'	0
Available For Sale Securities Net Unrealized Losses	'	-3
Available-for-sale Securities	'	14,930
Short Term Marketable Securities [Member] | US Government-sponsored Enterprises Debt Securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Available-for-sale Securities, Amortized Cost Basis	'	1,065
Available For Sale Securities Net Unrealized Gains	'	0
Available For Sale Securities Net Unrealized Losses	'	0
Available-for-sale Securities	'	1,065
Short Term Marketable Securities [Member] | Municipal Notes [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Available-for-sale Securities, Amortized Cost Basis	552	'
Available For Sale Securities Net Unrealized Gains	1	'
Available For Sale Securities Net Unrealized Losses	0	'
Available-for-sale Securities	553	'
Short Term Marketable Securities [Member] | US Treasury Securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Available-for-sale Securities, Amortized Cost Basis	'	4,510
Available For Sale Securities Net Unrealized Gains	'	0
Available For Sale Securities Net Unrealized Losses	'	0
Available-for-sale Securities	'	4,510
Short Term Marketable Securities [Member] | Certificates of Deposit [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Available-for-sale Securities, Amortized Cost Basis	'	1,800
Available For Sale Securities Net Unrealized Gains	'	0
Available For Sale Securities Net Unrealized Losses	'	0
Available-for-sale Securities	'	$1,800

Net_Loss_Per_Share_Details

Net Loss Per Share (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2013	Sep. 29, 2012	Sep. 28, 2013	Sep. 29, 2012
Earnings Per Share Reconciliation [Abstract]	'	'	'	'
Net loss	$13,561	($11,246)	($29,273)	($22,413)
Shares for net income (loss) per share:	'	'	'	'
Weighted-average shares outstanding—Basic	157,105	163,838	159,057	165,143
Dilutive securities	6,812	0	0	0
Weighted-average shares outstanding—Diluted	163,917	163,838	159,057	165,143

Net_Loss_Per_Share_Antidilutiv

Net Loss Per Share - Antidilutive Securities (Details)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2013	Sep. 29, 2012	Sep. 28, 2013	Sep. 29, 2012	Dec. 31, 2012
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	36,631	'	36,631	'	33,241
Antidilutive securities	8,851	33,372	36,771	33,372	'

Selected_Financial_Statement_I2

Selected Financial Statement Information (Details) (USD $)	Sep. 28, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Accounts Receivable, Net [Abstract]	'	'
Trade accounts receivable	$174,011	$132,782
Allowance for doubtful accounts	20	53
Accounts Receivable, net	173,991	132,729
Inventory, Net [Abstract]	'	'
Raw materials	30,075	26,798
Work-in-process	108,625	72,393
Finished goods	36,883	39,055
Inventories	175,583	138,246
Other Assets, Current [Abstract]	'	'
Precious metals reclaim	41,397	39,472
Other	10,049	8,910
Other current assets	51,446	48,382
Employee-related Liabilities, Current [Abstract]	'	'
Accrued payroll and taxes	8,379	11,234
Accrued paid time off and sabbatical	17,220	14,979
Accrued management incentive program	3,306	2,437
Self-insurance liability	2,409	2,168
ESPP Withholdings	6,868	2,436
Accrued payroll	$38,182	$33,254

Property_Plant_and_Equipment_P

Property, Plant and Equipment Property, Plant and Equipment (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2013	Sep. 29, 2012	Sep. 28, 2013	Sep. 29, 2012	Dec. 31, 2012
Property, Plant and Equipment [Line Items]	'	'	'	'	'
Total property, plant and equipment, gross	$998,001	'	$998,001	'	$923,612
Accumulated depreciation	-543,764	'	-543,764	'	-474,871
Total property, plant and equipment, net	454,237	'	454,237	'	448,741
Depreciation, Depletion and Amortization [Abstract]	'	'	'	'	'
Depreciation expense	26,495	22,701	74,992	64,352	'
Land	'	'	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'	'	'
Total property, plant and equipment, gross	19,718	'	19,718	'	19,691
Buildings	'	'	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'	'	'
Total property, plant and equipment, gross	95,080	'	95,080	'	94,766
Building and leasehold improvements	'	'	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'	'	'
Total property, plant and equipment, gross	32,021	'	32,021	'	31,012
Machinery and equipment	'	'	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'	'	'
Total property, plant and equipment, gross	755,891	'	755,891	'	664,737
Furniture and fixtures	'	'	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'	'	'
Total property, plant and equipment, gross	7,007	'	7,007	'	6,915
Computer equipment and software	'	'	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'	'	'
Total property, plant and equipment, gross	51,742	'	51,742	'	46,930
Assets in process	'	'	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'	'	'
Total property, plant and equipment, gross	$36,542	'	$36,542	'	$59,561

Goodwill_and_Other_Acquisition2

Goodwill and Other Acquisition-Related Intangible Assets (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2013	Sep. 29, 2012	Sep. 28, 2013	Sep. 29, 2012	Dec. 31, 2012
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Goodwill, Impairment Loss	'	'	$0	'	'
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	'	'	0	'	'
Goodwill	13,790	'	13,790	'	4,391
Finite-Lived Intangible Assets, Gross	64,622	'	64,622	'	57,522
Finite-Lived Intangible Assets, Accumulated Amortization	-40,471	'	-40,471	'	-35,209
Finite-Lived Intangible Assets, Net	24,151	'	24,151	'	22,313
Intangible Assets Finite and Indefinite Lived, Gross (Excluding Goodwill)	65,472	'	65,472	'	58,372
Intangible Assets, Net (Excluding Goodwill)	25,001	'	25,001	'	23,163
Intangible Assets Gross Including Goodwill	79,262	'	79,262	'	62,763
Intangible Assets Net Including Goodwill	38,791	'	38,791	'	27,554
Change in Gross Goodwill and Intangible Assets	'	'	0	'	'
Amortization of Intangible Assets	1,730	1,649	5,262	4,805	'
Fair Value of Assets Acquired	'	'	16	'	'
Acquisition of business, net of cash acquired	'	'	5,940	3,000	'
In Process Research And Development Non Amortizing [Member]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Indefinite-Lived Intangible Assets, Gross (Excluding Goodwill)	850	'	850	'	850
Indefinite-lived Intangible Assets	850	'	850	'	850
Goodwill [Member]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Goodwill	13,790	'	13,790	'	4,391
Indefinite-lived Intangible Assets Acquired	'	'	9,399	'	'
In Process Research and Development [Member]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Finite-Lived Intangible Assets, Gross	1,779	'	1,779	'	1,779
Finite-Lived Intangible Assets, Accumulated Amortization	-973	'	-973	'	-658
Finite-Lived Intangible Assets, Net	806	'	806	'	1,121
Developed Technology Rights [Member]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Finite-lived Intangible Assets Acquired	'	'	5,000	'	'
Patents Trademarks And Other [Member]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Finite-Lived Intangible Assets, Gross	62,843	'	62,843	'	55,743
Finite-Lived Intangible Assets, Accumulated Amortization	-39,498	'	-39,498	'	-34,551
Finite-Lived Intangible Assets, Net	23,345	'	23,345	'	21,192
Customer Relationships [Member]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Finite-lived Intangible Assets Acquired	'	'	1,500	'	'
Trademarks and Trade Names [Member]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Finite-lived Intangible Assets Acquired	'	'	600	'	'
Deferred Tax Asset [Domain]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Finite-lived Intangible Assets Acquired	'	'	1,665	'	'
Minimum [Member] | In Process Research and Development [Member]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Finite-Lived Intangible Assets, Useful Life (years)	'	'	'3 years	'	'
Minimum [Member] | Patents Trademarks And Other [Member]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Finite-Lived Intangible Assets, Useful Life (years)	'	'	'4 years	'	'
Maximum [Member] | In Process Research and Development [Member]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Finite-Lived Intangible Assets, Useful Life (years)	'	'	'5 years	'	'
Maximum [Member] | Patents Trademarks And Other [Member]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Finite-Lived Intangible Assets, Useful Life (years)	'	'	'15 years	'	'
Increase [Member]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Change in Gross Goodwill and Intangible Assets	'	'	16,499	'	'
Increase [Member] | In Process Research And Development Non Amortizing [Member]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Indefinite-lived Intangible Assets, Period Increase (Decrease)	'	'	0	'	'
Increase [Member] | Goodwill [Member]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Goodwill, Period Increase (Decrease)	'	'	9,399	'	'
Increase [Member] | In Process Research and Development [Member]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Finite-Lived Intangible Assets, Period Increase (Decrease)	'	'	0	'	'
Increase [Member] | Patents Trademarks And Other [Member]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Finite-Lived Intangible Assets, Period Increase (Decrease)	'	'	7,100	'	'
CAP Wireless [Member]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Acquisition of business, net of cash acquired	'	'	$14,850	'	'
CAP Wireless [Member] | Minimum [Member] | Patents Trademarks And Other [Member]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Finite-Lived Intangible Assets, Useful Life (years)	'	'	'3 years	'	'
CAP Wireless [Member] | Maximum [Member] | Patents Trademarks And Other [Member]	'	'	'	'	'
Goodwill And Finite And Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Finite-Lived Intangible Assets, Useful Life (years)	'	'	'14 years	'	'

Credit_Facility_Details

Credit Facility (Details) (USD $)	3 Months Ended	9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2013	Sep. 28, 2013	Sep. 29, 2012	Dec. 31, 2012
Lenders Credit Agreement [Member]	'	'	'	'
Line of Credit Facility [Line Items]	'	'	'	'
Line of Credit Facility, Expiration Date	'	30-Sep-14	'	'
Bank of America Credit Agreement [Member]	'	'	'	'
Line of Credit Facility [Line Items]	'	'	'	'
Line of Credit Facility, Maximum Borrowing Capacity	$200,000	$200,000	'	'
Line of Credit Facility, Interest Rate Description	'	'The Applicable Rate for Eurodollar Rate loans is based on the Company’s consolidated total leverage ratio (as defined in the Agreement) and is subject to a floor of 2.50% per annum and a cap of 3.00% per annum. Base Rate loans bear interest at a rate equal to the higher of the federal funds rate plus 0.50%, the prime rate of Bank of America, N.A. plus the Applicable Rate or the Eurodollar Base Rate plus 1.0%. The Applicable Rate for Base Rate loans is subject to a floor of 1.50% per annum and a cap of 2.00% per annum.	'	'
Line of Credit Facility, Covenant Terms	'	'The Agreement requires the Company to maintain ratios defined in the Agreement, which include a consolidated total leverage ratio as of the end of any fiscal quarter not in excess of 2.50 to 1.00, a consolidated liquidity ratio of at least 1.25 to 1.00 and a consolidated interest coverage ratio at a minimum of 3.00 to 1.00.	'	'
Short-term Debt, Average Outstanding Amount	12,967	4,502	'	'
Line of Credit Facility, Maximum Total Leverage Ratio Allowed	'	2.5	'	'
Line of Credit Facility, Minimum Consolidated Liquidity Ratio Required	'	1.25	'	'
Line of Credit Facility, Minimum Consolidated Interest Coverage Ratio Required	'	3	'	'
Credit facility borrowing	'	'	'	0
Borrowing on credit facility	'	0	'	'
Interest Cost	$118	$121	$0	'
Eurodollar Rate Loan [Member]	'	'	'	'
Line of Credit Facility [Line Items]	'	'	'	'
Line of Credit Interest Rate Floor	2.50%	2.50%	'	'
Line of Credit Interest Rate Cap	3.00%	3.00%	'	'
Base Rate Loan [Member]	'	'	'	'
Line of Credit Facility [Line Items]	'	'	'	'
Line of Credit Interest Rate Floor	1.50%	1.50%	'	'
Line of Credit Interest Rate Cap	2.00%	2.00%	'	'
Federal Funds Rate [Member] | Base Rate Loan [Member]	'	'	'	'
Line of Credit Facility [Line Items]	'	'	'	'
Debt Instrument, Basis Spread on Variable Rate	'	0.50%	'	'
Eurodollar Rate [Member] | Base Rate Loan [Member]	'	'	'	'
Line of Credit Facility [Line Items]	'	'	'	'
Debt Instrument, Basis Spread on Variable Rate	'	1.00%	'	'

StockBased_Compensation_Detail

Stock-Based Compensation (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2013	Sep. 29, 2012	Sep. 28, 2013	Sep. 29, 2012
Stock-Based Compensation Expense Allocation [Line Items]	'	'	'	'
Stock-based Compensation Expense	$6,913	$7,364	$21,129	$21,619
Cost of Goods Sold [Member]	'	'	'	'
Stock-Based Compensation Expense Allocation [Line Items]	'	'	'	'
Stock-based Compensation Expense	1,720	2,549	5,327	6,477
Research and Development Expense [Member]	'	'	'	'
Stock-Based Compensation Expense Allocation [Line Items]	'	'	'	'
Stock-based Compensation Expense	2,802	2,226	7,897	6,914
Selling, General And Administrative [Member]	'	'	'	'
Stock-Based Compensation Expense Allocation [Line Items]	'	'	'	'
Stock-based Compensation Expense	$2,391	$2,589	$7,905	$8,228

StockBased_Compensation_Option

Stock-Based Compensation - Option Transactions (Details) (USD $)	9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 28, 2013
Options Outstanding [Roll Forward]	'
Options outstanding at the beginning of the period (shares)	33,241
Options outstanding at the beginning of the period (weighted-average exercise price per share)	$6.56
Options granted (shares)	7,015
Options granted (weighted-average exercise price per share)	$5.86
Options exercised (shares)	-2,435
Options exercised (weighted-average exercise price per share)	$4.59
Options forfeited (shares)	-1,190
Options forfeited (weighted-average exercise price per share)	$7.27
Options outstanding at the end of the period (shares)	36,631
Options outstanding at the end of the period (weighted-average exercise price per share)	$6.53

StockBased_Compensation_StockB

Stock-Based Compensation Stock-Based Compensation - Restricted Stock Units (Details) (Restricted Stock Units (RSUs) [Member], USD $)	9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 28, 2013
Restricted Stock Units (RSUs) [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]	'
Units outstanding at the beginning of the period (shares)	0
Units outstanding at the beginning of the period (weighted average grant date fair value per share)	$0
Units Granted in Period (shares)	100
Units granted during the period (weighted average grant date fair value per share)	$7.76
Units outstanding at the end of the period (shares)	100
Units outstanding at the end of the period (weighted average grant date fair value per share)	$7.76

StockBased_Compensation_StockB1

Stock-Based Compensation Stock-Based Compensation - Market-Based Restricted Stock Units (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 28, 2013	Sep. 29, 2012	Sep. 28, 2013	Sep. 29, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Share-based compensation arrangement by share based payment award, maximum potential shares	299	'	299	'
Market-based restricted stock units	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	0.40%	0.00%	0.40%	0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%	0.00%	0.00%	0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	56.20%	0.00%	56.20%	0.00%
TQNT correlation coefficient to SPDR	59.00%	0.00%	59.00%	0.00%
Share-based compensation arrangement by share based payment award, percentage of target shares presented	'	'	100.00%	'
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]	'	'	'	'
Units outstanding at the beginning of the period (shares)	'	'	0	'
Units outstanding at the beginning of the period (weighted average grant date fair value per share)	'	'	$0	'
Units Granted in Period (shares)	'	'	199	'
Units granted during the period (weighted average grant date fair value per share)	'	'	$7.45	'
Units outstanding at the end of the period (shares)	199	'	199	'
Units outstanding at the end of the period (weighted average grant date fair value per share)	$7.45	'	$7.45	'
Market-based restricted stock units | Minimum [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Share-based compensation arrangement by share based payment award, percentage of target shares awarded	0.00%	'	0.00%	'
Market-based restricted stock units | Maximum [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Share-based compensation arrangement by share based payment award, percentage of target shares awarded	150.00%	'	150.00%	'

StockBased_Compensation_Employ

Stock-Based Compensation - Employee Stock Purchase Program (Details) (Employee Stock Purchase Plan [Member])	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2013	Sep. 29, 2012	Sep. 28, 2013	Sep. 29, 2012
Employee Stock Purchase Plan [Member]	'	'	'	'
Employee Stock Purchase Plan [Abstract]	'	'	'	'
Shares purchased	0	0	1,872	1,770

Income_Taxes_Details

Income Taxes (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2013	Sep. 29, 2012	Sep. 28, 2013	Sep. 29, 2012	Dec. 31, 2012
Income Tax Disclosure [Abstract]	'	'	'	'	'
Income tax expense (benefit)	$4,137	$5,139	($6,119)	($5,104)	'
Deferred Tax Assets, Tax Credit Carryforwards, Research	4,045	'	4,045	'	'
Undistributed Earnings of Foreign Subsidiiaries	104,497	'	104,497	'	'
Deferred Tax Assets, Net	75,220	'	75,220	'	69,715
Deferred Tax Assets, Valuation Allowance	15,558	'	15,558	'	14,518
Unrecognized Tax Benefits, Period Increase (Decrease)	'	'	1,261	'	'
Net unrecognized tax benefits	$4,070	'	$4,070	'	$2,809

Investment_in_CyOptics_Inc_Inv

Investment in CyOptics, Inc. Investment in CyOptics (Details) (USD $)	0 Months Ended	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	11-May-05	Sep. 28, 2013	Sep. 29, 2012	Sep. 28, 2013	Sep. 29, 2012	Dec. 31, 2011
Cost-method Investments, Realized Gain (Loss), Alternative [Abstract]	'	'	'	'	'	'
Consideration in preferred stock received	$4,500	'	'	'	'	'
Receipt of unsecured promissory note	5,633	'	'	'	'	'
Cost Method Investments	'	'	'	'	'	0
Gain/recovery of investment	'	$0	$0	$421	$6,957	'

Stock_Repurchase_Program_Stock1

Stock Repurchase Program Stock Repurchase Program (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2013	Sep. 29, 2012
Payments for Repurchase of Equity [Abstract]	'	'
Stock Repurchase Program, Authorized Amount	$75,000	'
Stock Repurchased During Period, Shares	7,670	4,879
Repurchase of common stock	$51,125	$25,000

Subsequent_Events_Subsequent_E1

Subsequent Events Subsequent Events (Details) (Loss on Disposal of Assets [Member], USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2013
Minimum [Member]	'
Subsequent Event [Line Items]	'
Loss on Disposal of Assets	$20,000
Maximum [Member]	'
Subsequent Event [Line Items]	'
Loss on Disposal of Assets	$25,000